Millennium UN Plaza Hotel
Hear from government regulators, in-house pharmaceutical counsel, and expert attorneys on the front lines of the complex antitrust issues currently facing brand name and generic pharmaceutical manufacturers and learn how to:
- Structure reverse settlement payment agreements that align with FTC concerns
- Negotiate mergers in the wake of Pfizer/Wyeth, Teva/Barr and the revised Guidelines
- Comprehend the impact of Ovation on product acquisitions
- Update life cycle management strategies, including product migration, authorized generics and tactics for follow-on biologic products Navigate increased overseas focus by global regulators
- Work more effectively with the FtC by gaining greater understanding of how the Commission operates
- Meet emerging pricing and distribution concerns following health care reform
Washington partner, John Roberti will be speaking. For more information about this event, please click here.
Related Capabilities
Events
-
May 132021
2021 Structured Products Legal, Regulatory & Market Briefing
Hosted By The Structured Products Association
Stay up-to-date on our perspectives
Subscribe to Email